ArticleBreast cancer research : BCR2022

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.

Dennis C Sgroi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.